Watertown, MA · $235K–$330K
Posted Jul 24, 2026 · 15+ years required
Opens Kymera Therapeutics, Inc.'s own application page in a new tab, this page stays open behind it.
Director, Total Rewards
Named on Kymera Therapeutics, Inc.'s FY2026 H-1B filings
Sign in to see their name and work email, plus a short intro note you can edit and send. You reach a person instead of dropping your resume into another online form. Not always the recruiter for this opening.
Create a free accountFiling data last recomputed Aug 9, 2026.
Sponsor score is an evidence index from 0 to 100, built from this employer's past public DOL and USCIS filings. It is not a probability that this role will sponsor you. Read how scores work.
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn.
The Senior Director of Early Phase Formulation Development will provide scientific leadership for preformulation and early stage formulation activities across our portfolio of small molecule programs. This individual will serve as a hands-on scientific expert and team leader, driving enabling formulation strategies from candidate selection through early clinical development, with a focus on solving complex drug delivery and bioavailability challenges inherent to degrader molecules. The successful candidate will partner closely with Research, DMPK, and CMC functions to advance programs efficiently through IND and into early-stage clinical studies. This role requires deep scientific expertise in enabling formulation technologies, a strong track record in early-stage pharmaceutical development, and the ability to work collaboratively across functions in a fast-paced biotech environment.
Responsibilities
Equal Employment Opportunity
Kymera Therapeutics is proud to be an equal opportunity employer, seeking to create a welcoming and diverse environment. All applicants will receive consideration for employment without regard to race, color, religion, creed, gender, national origin, age, disability, veteran status, pregnancy, sex, marital status, gender expression or identity, genetic information, sexual orientation, citizenship, or any other legally protected class.
Compensation